Related Experiment Video
Updated: Jun 13, 2025
06:39
Bioluminescence Imaging of Heme Oxygenase-1 Upregulation in the Gua Sha Procedure
Published on: August 28, 2009
14.0K
Heme Oxygenase-1 and Prostate Cancer: Function, Regulation, and Implication in Cancer Therapy
Ramia J Salloom1, Iman M Ahmad2, Dania Z Sahtout1
1Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
International Journal of Molecular Sciences
|September 14, 2024
Summary
Heme oxygenase-1 (HO-1) impacts prostate cancer (PC) growth, metastasis, and treatment resistance. Targeting HO-1 offers potential for novel therapies and improved patient outcomes in prostate cancer management.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Prostate cancer (PC) is a leading cause of cancer mortality in men.
- Understanding PC molecular mechanisms is crucial for effective treatment.
- Heme oxygenase-1 (HO-1) is implicated in various cancers, including PC.
Purpose of the Study:
- To review the multifaceted role of HO-1 in prostate cancer.
- To explore HO-1's influence on PC progression, therapy resistance, and immune modulation.
- To discuss the therapeutic potential and clinical implications of targeting HO-1 in PC.
Main Methods:
- Literature review of studies on HO-1 in prostate cancer.
- Analysis of HO-1's functions including proliferation, apoptosis, angiogenesis, and immune response.
- Examination of HO-1's role in treatment resistance and its prognostic value.
Main Results:
- HO-1 significantly influences PC cell proliferation, survival, angiogenesis, and the tumor microenvironment.
- HO-1 is associated with resistance to standard PC treatments.
- HO-1 modulates the tumor immune microenvironment, impacting therapy outcomes.
Conclusions:
- HO-1 plays a complex role in prostate cancer progression and therapy response.
- Targeting HO-1 presents a potential therapeutic strategy for PC.
- Further research into HO-1 is vital for developing personalized and effective PC treatments.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
187
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
187
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:24Peroxisomes
11.3K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
11.3K